ASX:PKS

PKS (PKS) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PKS stock logo

About PKS Stock (ASX:PKS)

PKS Holdings Limited, a healthcare technology company, develops and commercializes proprietary subscription based clinical decision support (CDS) systems that automates the human decision-making process in healthcare organizations in Australia and internationally. The company offers RippleDown Expert, an CDS system that provides real-time patient monitoring, alerting, data mining, and reporting capability; and RippleDown Auditor, a knowledge based system that allows various departments within a laboratory, including data entry, billing, and specimen reception to audit data in real-time. It also provides LabQ, a data mining tool; PICQ, an auditing tool used in hospital that assesses every record clinically coded for data quality; RISQ to provide industry benchmark of hospital-acquired complications incidence and underlying data quality; and Codexpert, a web-based eBook application providing the full health-data classification reference for clinical coding of patient episodes. The company serves customers through direct sales and channel partners. The company was formerly known as QPro Holdings Limited. PKS Holdings Limited was founded in 1996 and is headquartered in Redfern, Australia.

PKS Stock News Headlines

Protect Yourself While There’s Still Time …
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
Protect Yourself While There’s Still Time …
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
See More Headlines
Receive PKS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PKS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$5.97 million
Book Value
A$0.16 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Paul Richard O'Connor
    Exec.
  • Mr. Michael B. Pollitt
    Exec.
  • Mr. Tim Kelsey
    Chief Exec. Officer
  • Mr. Andrew William Bursill C.A. (Age 50)
    B.Agr.Ec., CA, Chief Financial Officer
  • Dr. Lindsay Peters
    Chief Technical Officer
  • Mr. Michael Reakes
    Gen. Mang.
  • Belinda Cleminson
    Company Sec.
  • Douglas Henry
    Exec.

This page (ASX:PKS) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners